000220 — Yuyu Pharma Income Statement
0.000.00%
Last trade - 00:00
- KR₩75bn
- KR₩86bn
- KR₩137bn
- 35
- 67
- 58
- 54
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 90,878 | 98,120 | 115,655 | 138,881 | 137,210 |
Cost of Revenue | |||||
Gross Profit | 46,610 | 45,269 | 45,335 | 53,313 | 48,897 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 82,831 | 91,905 | 114,455 | 139,917 | 137,425 |
Operating Profit | 8,047 | 6,215 | 1,200 | -1,036 | -215 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6,600 | 3,711 | -383 | -3,810 | -5,442 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,563 | 2,413 | -920 | -4,425 | -5,541 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4,722 | 1,284 | -2,214 | -5,988 | -7,181 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,437 | 999 | -2,499 | -6,273 | -7,207 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 332 | 68.6 | -156 | -359 | -416 |
Dividends per Share |